A randomised, placebo-controlled, double-blind phase III study of sequential administration of Tarceva (erlotinib) or placebo in combination with gemcitabine/platinum as first-line treatment in patients with stage IIIB/V non-small cell lung cancer (NSCLC)


Grant Data
Project Title
A randomised, placebo-controlled, double-blind phase III study of sequential administration of Tarceva (erlotinib) or placebo in combination with gemcitabine/platinum as first-line treatment in patients with stage IIIB/V non-small cell lung cancer (NSCLC)
Principal Investigator
Dr Ho, James Chung Man   (Principal investigator)
Co-Investigator(s)
Dr Lam Jamie Chung Mei   (Co-Investigator)
Dr Wang Julie Kwan Ling   (Co-Investigator)
Dr Lam David Chi Leung   (Co-Investigator)
Dr Wong Matthew King Yan   (Co-Investigator)
Duration
53
Start Date
2009-04-01
Completion Date
2013-08-31
Amount
358317
Conference Title
Presentation Title
Keywords
stage IIIB/V NSCLC
Discipline
Respiration,Cancer
Panel
Medicine
Grant Type
Pharmaceutical Industry - General Award
Funding Year
2008/2009
Status
On-going